130007-53-3

minotensin

5-Isoxazolidinemethanol, 2-methyl-3-(2-naphthalenyl)-, (3R,5S)-rel-

4-Isothiazolecarbonitrile, 3-(methylthio)-5-[4-(3-phenylpropoxy)phenyl]-

4H-Pyrazolo[3,4-d]pyrimidin-4-one,3-ethyl-1,5-dihydro-6-[(3-hydroxyphenyl)methyl]-1-(2,4,6-trichlorophenyl)-

4H-Thieno[3,2-b]pyrrole-5-carboxamide,N-[(1S)-2-[(3S,4R)-3,4-dihydroxy-1-pyrrolidinyl]-2-oxo-1-(phenylmethyl)ethyl]-2-methyl-

5-Isoxazolecarbonitrile,4,5-dihydro-3-[3-methoxy-4-(phenylmethoxy)phenyl]-

4H-Thieno[2,3-d]azepine-8-carboxylic acid,6-(3,4-difluorobenzoyl)-5,6-dihydro-4,4-dimethyl-, ethyl ester

Benzoic acid,3-[[1-[(3-methylphenyl)methyl]-1H-benzimidazol-2-yl]methoxy]-, methylester

4-Imidazolidinone,5-[(4-methoxyphenyl)methylene]-3-(1-piperazinylmethyl)-2-thioxo-, (5Z)-

4H-Pyrrolo[2,3-d]pyrimidin-4-one,2-amino-1,7-dihydro-5-(3-hydroxypropyl)-

5-Isoxazolecarboxamide, N-phenyl-

POLY(N-BUTYL ACRYLATE/2-METHACRYLOXYETHYLTRIMETHYLAMMONIUM BROMIDE) 80:20, 20% SOLN. IN WATER

6-methyl-N-(4-methylphenyl)-4-naphthalen-1-yl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxamide

4H-Pyrrolo[2,3-d]pyrimidin-4-one,2-(3-fluorophenyl)-1,7-dihydro-5,6-dimethyl-

(2S,6S)-6-ethyl-3,11-dimethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol hydrochloride (1:1)

Benzoic acid,2-[[3-carboxy-5-(1,1-dimethylethyl)phenyl]methoxy]-6-(2-mercaptoethyl)-

5-Isoxazolidinone, 4-(1-methylethyl)-2-[(1S)-1-phenylethyl]-, (4R)-

4H-Thieno[2,3-d]azepine,2,3-dichloro-5,6,7,8-tetrahydro-6-(phenylmethyl)-

Benzene, 1-[(6,6-dichloro-3-methyl-2,5-hexadienyl)oxy]-4-ethyl-

4H-Thieno[2,3-d]azepine,2-[(2-chloro-6-fluorophenyl)methyl]-5,6,7,8-tetrahydro-

Acetamide, N-(2-chlorooctyl)-

5-Isoxazolidinemethanol, 3-(2-methoxyphenyl)-2-methyl-, (3R,5S)-rel-

2-Azetidinone, 3-chloro-4,4-dimercapto-1-(3-nitrophenyl)-,monosodium salt

4H-Thieno[3,2-b]pyrrole-5-carboxylic acid, 2-chloro-

4H-Pyrrolo[2,3-d]pyrimidin-4-one,1,7-dihydro-7-(4-iodophenyl)-5-(4-methoxyphenyl)-, hydrazone

4-Isoxazolecarboxamide, N-(2-aminophenyl)-3-methyl-5-phenyl-

5-Isoxazoleacetic acid, 3-benzoyl-

4H-Pyrazolo[3,4-d]pyrimidin-4-one,3-ethyl-1,5-dihydro-6-(2-pyridinylmethyl)-1-(2,4,6-trichlorophenyl)-

4H-Thieno[3,2-b]pyrrole-5-carboxamide,2-bromo-N-[(1S,2R)-3-[(3S,4R)-3,4-dihydroxy-1-pyrrolidinyl]-2-hydroxy-3-oxo-1-(phenylmethyl)propyl]-

4H-Pyrazolo[3,4-d]pyrimidin-4-one, 1,5-dihydro-6-(4-nitrophenyl)-

4H-Pyrrolo[2,3-d]pyrimidin-4-one,7-(3-chlorophenyl)-1,7-dihydro-5,6-dimethyl-

4H-Pyrrolo[2,3-d]pyrimidin-4-one,1,7-dihydro-5,6-dimethyl-7-[3-(4-morpholinyl)propyl]-, hydrazone

5-Isoxazolidinemethanol, 2-methyl-3-(3-methyl-2-pyridinyl)-,(3R,5R)-rel-

4-Isothiazolecarbonitrile, 3-chloro-5-(4-methoxyphenoxy)-

5-Isoxazolidinecarbonitrile, 5-methyl-3-phenyl-2-(phenylmethyl)-,(3R,5R)-rel-

4H-Pyrrolo[2,3-d]pyrimidin-4-one,1,7-dihydro-5,6-dimethyl-2-(3-pyridinyl)-

4H-Thieno[3,2-b]pyrrole-5-carboxamide,3-bromo-N-[(1S)-2-[(3S,4R)-3,4-dihydroxy-1-pyrrolidinyl]-2-oxo-1-(phenylmethyl)ethyl]-

130007-53-3 msds

CAS No 130007-53-3 supplier

CASNo 130007-53-3 distributor

CAS # 130007-53-3 manufacturer

CAS Number 130007-53-3 safety

CAS RN 130007-53-3 wholesale

2026-10-09 minotensin,CAS No.130007-53-3,Formula:C41H47ClF3N11O6S2. Find Related Products for Bulk Production or Scientific Research